Rutgers
Receives $3
Million in Gifts
for Faculty
Position in Cell
Biology and
Neuroscience |
A $1.5-million
gift to the
Rutgers
University
Foundation will
help create a
new faculty
chair honoring
one of the
university’s
most successful
and respected
alumni – Greg
Brown, chairman
and chief
executive
officer of
Motorola
Solutions.
Motorola
Solutions’ Board
of Directors
announced the
gift to create
the Gregory Q.
Brown Endowed
Chair in Rutgers
University’s
Department of
Cell Biology and
Neuroscience in
recognition of
Brown’s
leadership and
impact at
Motorola.
The Department
of Cell Biology
and
Neuroscience, in
Rutgers
University’s
School of Arts
and Sciences, is
known worldwide
for its
groundbreaking
research to find
treatments for
stroke,
Alzheimer’s
disease, brain
and spinal cord
injuries, and
other
debilitating
conditions. The
gift will be
directed to this
department in
the hope that
Rutgers
researchers will
be able to
identify a cure
for dementia and
similar
diseases, as a
tribute to
Brown’s mother,
Winifred Brown,
who suffers from
dementia.
“My family and I
have seen
firsthand the
pain and
devastation
caused by
dementia,” Brown
said. “I am very
grateful and
deeply
appreciative to
the Motorola
Solutions Board
of Directors for
this
recognition.”
Motorola
Solutions’ gift
will be matched
with an
additional $1.5
million from an
anonymous donor
– part of a $27
million
challenge grant
to create 18
endowed faculty
chairs in a wide
range of
academic
disciplines
across Rutgers,
including
business
education,
engineering and
the sciences.
For every $1.5
million raised
for an endowed
chair that meets
the anonymous
donor’s
criteria, the
donor will match
the gift with an
additional $1.5
million. A total
endowment of $3
million is
needed to
establish an
academic chair.
Motorola
Solutions’ gift
creates the
third endowed
faculty chair as
part of the
challenge
grant.
Fundraising for
endowed chairs
is a top
priority of Our
Rutgers, Our
Future, the
university's
historic $1
billion
fundraising
campaign, said
Rutgers
University
Foundation
President Carol
P. Herring.
“Endowed chairs
enable the
university to
attract and
retain faculty
and give them
the support they
need to conduct
research that
creates new
knowledge and
benefits
humanity,”
Herring said.
“These faculty,
who are leaders
in their fields,
also provide our
undergraduate
and graduate
students with
unique learning
and research
opportunities.”
Launched
publicly in
October 2010,
Our Rutgers, Our
Future,
addresses
critical needs
across all areas
of the
university –
from faculty
research and
student
scholarships to
campus
construction and
civic
engagement.
Ninety percent
of the funds
raised in the
campaign will be
used to support
academic
initiatives,
facilities,
student services
and community
outreach. Top
|
Franck Barrat
Joins Roche as
Distinguished
Scientist |
Roche announces
that Franck
Barrat, PhD, has
joined the
Inflammation
Discovery and
Translational
Areas (DTA) as a
distinguished
scientist.
Franck, who
brings to Roche
extensive
interest and
expertise in the
roles that
dendritic cells,
toll receptor
agonists and
antagonists, and
IL10 secreting
regulatory T
cells play in
human diseases,
will report to
Jacques
Banchereau, PhD,
Chief Scientific
Officer-Nutley
and Head,
Inflammation and
Virology DTAs.
“Franck has
distinctive
experience in
early discovery
from target
identification
to IND filing
and early
proof-of-mechanism
clinical
studies. I am
delighted to
attract a
scholar of his
caliber to
Roche’s
Inflammation
discovery unit
and to Nutley
where his
expertise will
also be utilized
cross-functionally
within the
Virology and
Oncology DTAs,”
said Banchereau.
“I am certain he
will contribute
tremendously as
we continue to
build Nutley
into a vibrant,
research-focused
campus and
channel our
immunology
efforts into
discovering and
understanding
key pathways and
cell types that
drive disease
pathology.”
Prior to Roche,
Franck was at
Dynavax
Technologies in
Berkeley,
California,
where he held
several
positions over
the years --
most recently as
Senior Research
Fellow and
Project Leader
of the
Autoimmunity
Program. He
joined Dynavax
in 2001 after
completing a
post-doctoral
fellowship at
the DNAX
Research
Institute in
Palo Alto, where
he focused on
key signals in
the induction of
regulatory T
cells. At
Dynavax, Franck
discovered and
developed
DV1179, a
bifunctional
inhibitor of the
toll-like
receptors 7 and
9, which he led
from early
discovery work
to clinical
trials in lupus
patients. Most
of his research
at Dynavax was
supported by
highly
competitive NIH
funding.
Franck has
authored four
patents,
published nearly
40 papers, many
of these in
highly
prestigious
journals, and
has been an
invited speaker
at numerous
international
conferences. He
received his PhD
in Immunology
from the
University of
Paris, holds a
master’s degree
in Immunology
from the Pasteur
Institute and a
master’s degree
in Pharmacology
from the
University of
Nice. He is also
a member of the
American
Association of
Immunologists
and the Societe
Francaise
d’Immunologie. Top
|
Rothstein
Kass Adds Effin
Logue as Chief
People Officer |
Rothstein Kass,
a leading
national
professional
services
provider,
announces that
Effin Logue has
joined the firm
as its Chief
People Officer
(CPO). In this
newly created
position, Ms.
Logue will
oversee and
manage human
resources
functions at
Rothstein Kass
to promote
alignment with
firm-wide
business
strategy
initiatives. She
brings over 25
years of related
human resources
experience to
the position and
specializes in
total quality
management,
compensation,
diversity and
inclusion,
continuous
process
improvement,
self-directed
work team
implementation
and the creation
of human
resources
capabilities for
business
optimization.
Prior to joining
Rothstein Kass,
Ms. Logue spent
nearly 15 years
with Citibank,
most recently as
Director of
Human Resources
for the Global
Functions
Project
Management and
Operations
group.
Additional roles
Ms. Logue held
while at
Citibank
include: Global
HR Officer for
the Global
Functions of
Legal, Audit,
and HR, HR
Director for the
Shared Services
organization,
and Director of
Compensation,
Benefits, Policy
and Systems.
She has also
served as a
Manufacturing
Manager at
Mattel and
worked in
various human
resources
positions at
General
Electric, Allied
Signal, TRW, and
Beneficial
Management.
Ms. Logue earned
a Master of
Science degree
in Industrial
Relations &
Human Resources
from Rutgers
University and a
Bachelor of
Science degree
from the
University of
Colorado. She
is a Federal
Club member for
the Human Rights
Campaign, a
mentor in the
Big Brothers/Big
Sisters
Workplace
Mentoring
Program and a
member of the
Citigroup
Corporate Center
Women’s
Organization.
Top
|
|
|
|
|
New Jersey Business Digital Format
|
|
You can now order New Jersey Business either in traditional print format or as a digital format magazine. Using the latest digital publishing technology, a virtual facsimile of our magazine can be viewed directly on your computer screen, complete with realistic "page turning" effects.
Both formats are ideal ways to stay informed of business news and information in all 21 counties of the Garden State. To order, visit www.njbmagazine.com
To download our iPad App, visit the Apple Newsstand.
|
|
|
|
|
|
|
|
|
|
